E.U. Gives Up On Single Biotech Patent System
On Monday, the European Union’s executive body said it would allow countries to adopt different standards instead of insisting on a single European standard for patenting biotech drug innovations.
The Commission conceded that it was unlikely to reach an agreement on a single Europe-wide standard due in part to deep disagreements over...
To view the full article, register now.